John Wade appointed to Celltex Board of Directors

Celltex Therapeutics Corporation has named John Wade, Senior and Managing Partner of Wade & Company, LLP, to its Board of Directors, effective November 11, 2014. Wade brings more than 43 years of experience in public accounting and currently serves as the primary accountant and finance counsel for Celltex Therapeutics Corporation. Throughout his career, Wade has provided solutions to a wide variety of tax problems and counseled private and public companies regarding general business and tax planning matters. His tax practice … read more

Steering stem cell trafficking into pancreas reverses type 1 diabetes

Researchers at Brigham and Women’s Hospital, a Harvard-affiliated hospital, have been studying mesenchymal stem cells (MSCs) and have reportedly uncovered a way to enhance and prolong the cells’ therapeutic efforts in type 1 diabetes.  While studying a preclinical trial of diabetic-prone mice, Harvard Medical School Professor Robert Sackstein and a team of researchers found that the intravenous administration of MSCs stifled pancreatic injuries by reducing the levels of sugar in the bloodstream of those mice without the need of insulin … read more

Stem Cell in Eye May Help Restore Vision Following Cornea Injury, Infection

A recent study posted in Science Transitional Medicine suggests that mesenchymal stem cells from a patient’s own eye may one day replace corneal transplants. Dr. Sayan Basu and his team of doctors in India have been studying mesenchymal corneal stem cells for over a decade and have found that these cells can regenerate wounded corneal cells in mice far more effectively than the limbus stem cells that have already been through a clinical trial.  Researchers found that after 50,000 stem … read more

Celltex Sponsors Arthritis Foundation’s 2014 Bone Bash Gala

Costume party raises money and awareness for arthritis Celltex Therapeutics Corporation (Celltex) helped to sponsor the Arthritis Foundation’s 2014 Houston Bone Bash, the foundation’s signature costume gala. The Bone Bash, held on Saturday, October 25 at Hotel Derek, was established with the goal of raising awareness of arthritis and helping the foundation provide resources to those living with this disease and their caregivers. This year, the Bone Bash raised more than $260,000 for the Arthritis Foundation. David Eller, back left, … read more

Celltex Offers Stem Cell Holiday Banking Gift Certificate

Twenty percent off regular-priced banking fee Celltex is offering existing clients the opportunity to provide a gift of a lifetime to your family members this holiday season: a holiday banking gift certificate. This gift, deemed invaluable by many, provides family members with the security that their own mesenchymal stem cells will be safely banked for future therapeutic use. The banking package, priced at $5,200, is a timeless gift with no expiration date that includes a banking agreement for 20 percent … read more

$1.04 million grant from U.S. Army

Lipin Tang, a UT Arlington bioengineering professor aims to regenerate cartilage tissue and reduce osteoarthritis using a patient’s own stem cells (the same types of cells that Celltex uses in our technology) through the injection of microscaffolding. Tang, who is using a $1.04 million grant from the United States Army is focusing his research primarily on soldiers who were severely injured in battle and who now suffer from Posttraumatic Osteoarthritis. Posttraumatic Osteoarthritis often occurs in soldiers who suffered broken bones … read more

City scientists’ stem cell research could be boon for diabetics

The medical benefits of mesenchymal stem cells (MSCs), the same type of cells used by Celltex in our proprietary isolation and banking technology, are far-reaching. Researchers in Vadodara, India have conducted a study using MSCs that may be helpful for those using insulin to treat diabetes. Dr. Rajini Vyas and her team began the study in 2006 and focused on MSCs. Through the process of differentiation, Islet-like Cell Aggregates (ICA), which are clusters of cells that produce hormones, are created … read more

Celltex announces ‘joint’ partnership with Arthritis Foundation South Central Region

Houston-based biotechnology company Celltex Therapeutics Corporation is proud to announce a partnership with the Arthritis Foundation South Central Region. The coming together of these organizations marks a milestone for the future of regenerative medicine for people who are living with arthritis. Founded in 2011 by David Eller and internationally-known spine surgeon, Dr. Stanley Jones, Celltex has been generating breakthroughs in the autologous (ones own) stem cell field to improve the quality of life for those suffering from injuries or vascular, … read more

Stem Cell Treatment: Out from the Shadows, Onto the Cutting Edge released an intensive look into the number of professional athletes who are turning to adult mesenchymal stem cells (the kind that we all have in our own body and the same kind used by Celltex) to help them recover from sports-related injuries. According to the article published in late July, stem cell therapy is the next big breakthrough in sports medicine. Still, restrictions for use in the U.S. make stem cells an important and debated topic in regenerative medicine … read more

Celltex Supports Arthritis Foundation in Annual Joints in Action Golf Tournament

Celltex Therapeutics Corporation (Celltex) helped sponsor the Ninth Annual Joints in Action Golf Tournament, which invites golf enthusiasts to play a round for a good cause. The Tournament, founded by Dr. Bill Bryan and co-chaired by James Dumler and Lee Hollmann, took place on Thursday, August 28th at the Kingwood Country Club in Kingwood, TX, and honored Dr. Stanley Jones, chief medical officer at Celltex, as this year’s medical honoree. The annual charity event, which raises more than $200,000 every … read more